Search

everythinglearnresearchcommunity

for

Search:↓

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Low-intensity ultrasound may help protect hair follicles from chemotherapy-induced hair loss.

PPX causes much less hair loss than traditional taxanes.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The treatment is safe and shows promise for metastatic breast cancer.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Some drugs can cause permanent hair loss, though it's rare.

Some patients' hair grew back black and white after chemotherapy.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.